For the year ended December 31, 2025, two suppliers, namely Dongguan Chaoyang Pharmaceutical Co., Ltd and Guangzhou Guoying Pharmaceutical Co., Ltd., collectively accounted for 63.4% of our total pur…
For the year ended December 31, 2025, two suppliers, namely Dongguan Chaoyang Pharmaceutical Co., Ltd and Guangzhou Guoying Pharmaceutical Co., Ltd., collectively accounted for 63.4% of our total pur…
lity reasons. For other products under direct sales, we generally allow customers to return unused goods within seven days and to exchange defective goods. In respect of products of which we manage i…
yang Pharmaceutical Co., Ltd., accounted for 39.1% of our total purchases. For the year ended December 31, 2025, two suppliers, namely Dongguan Chaoyang Pharmaceutical Co., Ltd. and Guangzhou Guoying…
Pomdoctor Limited Debt Obligations
Instrument
Description
Confidence
Evidence
POM-DEBT-60871
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
POM-DEBT
Debt stack $66.8M
90%
Market cache reports total debt of $66.8M.
Pomdoctor Limited Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Pomdoctor Limited.
Pomdoctor Limited Ownership
Holder
Name
Confidence
Evidence
POM-OWNER-CITADEL-ADVISORS-LLC
CITADEL ADVISORS LLC
90%
13F overlay lists CITADEL ADVISORS LLC as top holder; 10 tracked holders.
Pomdoctor Limited Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.